Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis

被引：73

作者：

Bouma, BN

Mosnier, LO

机构：

[1] Scripps Res Inst, Dept Mol & Expt Med MEM 180, La Jolla, CA 92037 USA

[2] Univ Utrecht, Med Ctr, Dept Haematol, Thrombosis & Haemostasis Lab, Utrecht, Netherlands

来源：

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 2003年 / 33卷 / 5-6期

关键词：

TAFI; carboxypeptidase; coagulation; fibrinolysis;

D O I：

10.1159/000083832

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The thrombin-catalysed conversion of plasma fibrinogen into fibrin and the development of an insoluble fibrin clot are the final steps of the coagulation cascade during haemostasis. A delicate balance between coagulation and fibrinolysis determines the stability of the fibrin clot. Thrombin Activatable Fibrinolysis Inhibitor (TAFI) plays an important role in this process. TAFI is activated by thrombin and protects the fibrin clot against lysis. The role of TAFI in bleeding and thrombotic disorders is discussed as well as its novel emerging role in wound healing and inflammation. Copyright (C) 2004 S. Karger AG, Basel.

引用

收藏

页码：375 / 381

页数：7

相关论文

共 58 条

[41] Consequences of inhibition of plasma carboxypeptidase B on in vivo thrombolysis, thrombosis and hemostasis [J].

Refino, CJ ;

DeGuzman, L ;

Schmitt, D ;

Smyth, R ;

Jeet, S ;

Lipari, MT ;

Eaton, D ;

Bunting, S .

FIBRINOLYSIS & PROTEOLYSIS, 2000, 14 (05) :305-314

[42] Impaired wound healing in mice with a disrupted plasminogen gene [J].

Romer, J ;

Bugge, TH ;

Pyke, C ;

Lund, LR ;

Flick, MJ ;

Degen, JL ;

Dano, K .

NATURE MEDICINE, 1996, 2 (03) :287-292

[43] SUPERFICIAL ACCUMULATION OF PLASMINOGEN DURING PLASMA CLOT LYSIS [J].

SAKHAROV, DV ;

RIJKEN, DC .

CIRCULATION, 1995, 92 (07) :1883-1890

[44] Inherited factor XI deficiency confers no protection against acute myocardial infarction [J].

Salomon, O ;

Steinberg, DM ;

Dardik, R ;

Rosenberg, N ;

Zivelin, A ;

Tamarin, I ;

Ravid, B ;

Berliner, S ;

Seligsohn, U .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) :658-661

[45] Two naturally occurring variants of TAFI (Thr-325 and Il-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. [J].

Schneider, M ;

Boffa, M ;

Stewart, R ;

Rahman, M ;

Koschinsky, M ;

Nesheim, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1021-1030

[46] PRO-CARBOXYPEPTIDASE-R CLEAVES BRADYKININ FOLLOWING ACTIVATION [J].

SHINOHARA, T ;

SAKURADA, C ;

SUZUKI, T ;

TAKEUCHI, O ;

CAMPBELL, W ;

IKEDA, S ;

OKADA, N ;

OKADA, H .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1994, 103 (04) :400-404

[47]

Silveira A, 2000, THROMB HAEMOSTASIS, V84, P364

[48] Structural requirements for α9β1-mediated adhesion and migration to thrombin-cleaved osteopontin [J].

Smith, LL ;

Giachelli, CM .

EXPERIMENTAL CELL RESEARCH, 1998, 242 (01) :351-360

[49] Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha(9)beta(1) integrin [J].

Smith, LL ;

Cheung, HK ;

Ling, LE ;

Chen, J ;

Sheppard, D ;

Pytela, R ;

Giachelli, CM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28485-28491

[50] In vivo regulation of plasminogen function by plasma carboxypeptidase B [J].

Swaisgood, CM ;

Schmitt, D ;

Eaton, D ;

Plow, EF .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (09) :1275-1282

← 1 2 3 4 5 6 →